pneumadin has been researched along with Atrophy in 2 studies
*Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konwerska, A; Kosowicz, J; Malendowicz, LK; Miśkowiak, B; Nussdorfer, GG; Ziółkowska, A | 1 |
| Andreis, PG; Malendowicz, LK; Markowska, A; Miskowiak, B; Nussdorfer, GG | 1 |
2 other study(ies) available for pneumadin and Atrophy
| Article | Year |
|---|---|
Pneumadin in the ventral prostate and seminal vesicles of estradiol-treated rats: RIA and immunocytochemical studies.
Topics: Animals; Atrophy; Down-Regulation; Drug Administration Schedule; Epithelial Cells; Estradiol; Immunohistochemistry; Male; Oligopeptides; Prostate; Radioimmunoassay; Rats; Rats, Wistar; Reproduction; Seminal Vesicles | 2003 |
Effects of pneumadin (PNM) on the adrenal glands. 6. Further studies on the inhibitory effect of PNM on dexamethasone-induced atrophy of the rat adrenal cortex.
Topics: Adrenal Cortex; Aldosterone; Animals; Atrophy; Cell Size; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Female; Oligopeptides; Organ Size; Rats; Rats, Wistar; Time Factors | 1997 |